#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epstein-Barr virus infection Urethral valves Frostbite Crigler-Najjar syndrome Arrhythmogenic right ventricular dysplasia Hypocalcaemia Heart disease congenital Pleomorphic leiomyosarcoma Pulmonary alveolar haemorrhage Hypersomnia Pancreatic carcinoma Leukaemia Malformation venous Iron overload Deafness More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma – Trials in Disease Netherton’s syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Rett syndrome – Basic Information Vascular malformation – Life with Disease Progressive multifocal leukoencephalopathy – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Treatment Gaucher’s disease type III – Diagnostics Leiomyosarcoma – Diagnostics Ornithine transcarbamoylase deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pal1-15 Acetate VORMATRIGINE Threonine Juniper Berry Oil GOLD SODIUM THIOSULFATE Disitamab Vedotin Anhydrous Cyclophosphamide Dimeticone Dersimelagon Phosphate VOROLANIB Art6043 Duloxetine Dronedarone Ponsegromab HLX43 BMS-986470 Ly3298176 Quercus Ilex Allergen Extract Pemetrexed Disodium Levocabastine Hydrochloride More therapies…

    Learn about Your Condition

    Colorectal adenocarcinoma Breast angiosarcoma metastatic Hepatitis alcoholic Amnestic disorder Hypomagnesaemia Amyotrophic lateral sclerosis Lymphangioleiomyomatosis HER2 positive gastric cancer Bladder cancer stage II Syphilis Synovitis Prostate cancer recurrent Metastases to rectum Diabetes insipidus Klinefelter's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Indocyanine Green for Evaluating Blood Flow in Surgery for Women with Recurrent or Persistent Gynecological Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Indocyanine Green
    Italy

  • Study on the Effects of Belimumab for Patients with Systemic Lupus Erythematosus (SLE)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Belimumab
    The Netherlands

  • Study on the Safety of Atezolizumab and Bevacizumab for Liver Transplant Patients with Advanced Liver Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Liver transplant
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    France

  • Study of Ziftomenib with Chemotherapy for Children with Relapsed or Refractory Acute Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ziftomenib
    • Hydrocortisone
    • Cytarabine
    Austria France Italy The Netherlands Spain

  • Study on the Effectiveness of Ambroxol and Clenbuterol in Children and Adults with Gaucher Disease Type 3

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ambroxol Hydrochloride
    • Clenbuterol Hydrochloride
    The Netherlands

  • Study on the Safety and Effectiveness of CTX001 for Children with Transfusion-Dependent Beta-Thalassemia Using Exagamglogene Autotemcel and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Thalassaemia
    Investigated Drugs:
    • Exagamglogene Autotemcel
    • Plerixafor
    • Filgrastim
    Germany Italy
Previous Page
1 … 310 311 312 313 314 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!